Pharma industry reputation settles into ‘new normal’ after goodwill from insulin price drop fades
Pharma’s reputation is settling into a consistent “new normal,” with now 45% of consumers reporting a positive perception of the industry, according to The Harris Poll’s latest survey data.
While that’s good news considering the industry’s much lower public regard before the pandemic, are there potential bumps — such as Medicare’s spotlight on drug pricing and negotiations — on the horizon?
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
